1182.98.4908 Boehringer Ingelheim Investigational Site

Hamburg

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC — Stopped early